Assessing new health technologies: lessons to be learned from drugs.
Where this comes from
- Record sourced from PubMed, PMID 10816710.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Balancing the interests of producers, consumers and purchasers (governments) increases the complexity of evidence-based evaluation of non-drug health technologies.